Showing results (2011-2020 of 2,866) with videos related to
Sort By:
Pageof 287
Dose-Response : a Publication of International Hormesis Society|September 30, 2010
Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and ApoptosisEmily C Chiang, Shuren Shen, Seema S Kengeri, et al.Critical Care (London, England)|August 20, 2016
The association of sleep quality, delirium, and sedation status with daily participation in physical therapy in the ICUBiren B Kamdar, Michael P Combs, Elizabeth Colantuoni, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 23, 2017
Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV OutbreakMonita R Patel, Carrie Foote, Joan Duwve, et al.Antiviral Research|August 14, 2021
Inhibiting cytomegalovirus replication through targeting the host electron transport chainJoseph A Combs, Chandler H Monk, Mark A A Harrison, et al.Plos One|December 3, 2014
The relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell linesDaniel Habermehl, Katarina Ilicic, Sarah Dehne, et al.Scientific Reports|June 29, 2019
Tremorgenic effects and functional metabolomics analysis of lolitrem B and its biosynthetic intermediatesPriyanka Reddy, Simone Rochfort, Elizabeth Read, et al.Hepatology (Baltimore, Md.)|December 1, 1996
Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulinN A Terrault, S Zhou, C Combs, et al.Circulation|November 1, 1996
Eliminating bradyarrhythmias after orthotopic heart transplantationS A Rothman, V Jeevanandam, W G Combs, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 10, 2009
Low adherence to national guidelines for thyroid screening in Down syndromeMark A Fergeson, John J Mulvihill, G Bradley Schaefer, et al.Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Benzoxazinones as PPARgamma agonists. part 1: SAR of three aromatic regionsPhilip J Rybczynski, Roxanne E Zeck, Donald W Combs, et al.Pageof 287